Technical Analysis for CKPT - Checkpoint Therapeutics, Inc.

Grade Last Price % Change Price Change
grade C 3.5 -1.13% -0.04
CKPT closed down 1.13 percent on Tuesday, February 19, 2019, on 22 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Down
See historical CKPT trend table...

Date Alert Name Type % Chg
Feb 19 New Downtrend Bearish 0.00%
Feb 19 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Feb 19 Doji - Bullish? Reversal 0.00%
Feb 19 Down 3 Days in a Row Weakness 0.00%
Feb 19 Down 4 Days in a Row Weakness 0.00%
Feb 19 Down 5 Days in a Row Weakness 0.00%
Feb 15 Fell Below 20 DMA Bearish -1.13%
Feb 15 1,2,3 Pullback Bullish Bullish Swing Setup -1.13%
Feb 15 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -1.13%
Feb 15 Down 3 Days in a Row Weakness -1.13%

Older signals for CKPT ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Checkpoint Therapeutics, Inc. is an immuno-oncology biopharmaceutical company. The Company is focused on the acquisition, development and commercialization of non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. The Company is engaged in developing a portfolio of human immuno-oncology targeted antibodies. The portfolio of antibodies that it licensed includes antibodies targeting programmed death-ligand 1 (PD-L1), glucocorticoid-induced Tumor necrosis factor receptor (TNFR) related protein (GITR) and carbonic anhydrase IX (CAIX). It focuses on developing the immuno-oncology and checkpoint inhibitor antibodies. It is developing three oral, small molecules, targeted anti-cancer agents, consisting of an inhibitor of epidermal growth factor receptor (EGFR) mutations, an inhibitor of the bromodomain and extra-terminal (BET) protein, BRD4, and an inhibitor of poly (ADP-ribose) polymerase (PARP). Its pipeline of products includes CK-101 and CK-103.
Medicine Immunology Antibodies Chemotherapy Immune System Cancer Immunotherapy Epidermal Growth Factor Receptor Solid Tumor Cancers Immune Checkpoint Checkpoint Inhibitor
Is CKPT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 6.29
52 Week Low 1.5
Average Volume 73,159
200-Day Moving Average 3.0551
50-Day Moving Average 2.8751
20-Day Moving Average 3.6505
10-Day Moving Average 3.753
Average True Range 0.3297
ADX 33.29
+DI 18.9589
-DI 20.785
Chandelier Exit (Long, 3 ATRs ) 3.2409
Chandelier Exit (Short, 3 ATRs ) 3.9791
Upper Bollinger Band 4.1641
Lower Bollinger Band 3.1369
Percent B (%b) 0.35
BandWidth 28.138611
MACD Line 0.1963
MACD Signal Line 0.2783
MACD Histogram -0.082
Fundamentals Value
Market Cap 88.79 Million
Num Shares 25.4 Million
EPS -1.10
Price-to-Earnings (P/E) Ratio -3.18
Price-to-Sales 75.20
Price-to-Book 6.30
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.00
Resistance 3 (R3) 3.97 3.78 3.91
Resistance 2 (R2) 3.78 3.65 3.79 3.88
Resistance 1 (R1) 3.64 3.58 3.71 3.67 3.86
Pivot Point 3.45 3.45 3.49 3.46 3.45
Support 1 (S1) 3.31 3.32 3.38 3.34 3.14
Support 2 (S2) 3.12 3.25 3.13 3.12
Support 3 (S3) 2.98 3.12 3.09
Support 4 (S4) 3.01